BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

498 related articles for article (PubMed ID: 21703181)

  • 1. Chronic intermittent hypoxia is a major trigger for non-alcoholic fatty liver disease in morbid obese.
    Aron-Wisnewsky J; Minville C; Tordjman J; Lévy P; Bouillot JL; Basdevant A; Bedossa P; Clément K; Pépin JL
    J Hepatol; 2012 Jan; 56(1):225-33. PubMed ID: 21703181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonalcoholic fatty liver disease, nocturnal hypoxia, and endothelial function in patients with sleep apnea.
    Minville C; Hilleret MN; Tamisier R; Aron-Wisnewsky J; Clement K; Trocme C; Borel JC; Lévy P; Zarski JP; Pépin JL
    Chest; 2014 Mar; 145(3):525-533. PubMed ID: 24264333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of obstructive sleep apnea on fatty liver disease: role of chronic intermittent hypoxia.
    Türkay C; Ozol D; Kasapoğlu B; Kirbas I; Yıldırım Z; Yiğitoğlu R
    Respir Care; 2012 Feb; 57(2):244-9. PubMed ID: 21762556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macrophage activation marker soluble CD163 and non-alcoholic fatty liver disease in morbidly obese patients undergoing bariatric surgery.
    Kazankov K; Tordjman J; Møller HJ; Vilstrup H; Poitou C; Bedossa P; Bouillot JL; Clement K; Grønbaek H
    J Gastroenterol Hepatol; 2015 Aug; 30(8):1293-300. PubMed ID: 25772748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of obstructive sleep apnea on nonalcoholic fatty liver disease in patients with severe obesity.
    Benotti P; Wood GC; Argyropoulos G; Pack A; Keenan BT; Gao X; Gerhard G; Still C
    Obesity (Silver Spring); 2016 Apr; 24(4):871-7. PubMed ID: 26880657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obstructive sleep apnea, insulin resistance, and steatohepatitis in severe obesity.
    Polotsky VY; Patil SP; Savransky V; Laffan A; Fonti S; Frame LA; Steele KE; Schweizter MA; Clark JM; Torbenson MS; Schwartz AR
    Am J Respir Crit Care Med; 2009 Feb; 179(3):228-34. PubMed ID: 18990675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between omental adipose tissue macrophages and liver histopathology in morbid obesity: influence of glycemic status.
    Tordjman J; Poitou C; Hugol D; Bouillot JL; Basdevant A; Bedossa P; Guerre-Millo M; Clement K
    J Hepatol; 2009 Aug; 51(2):354-62. PubMed ID: 19464069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic histopathology of morbid obesity: concurrence of other forms of chronic liver disease.
    Liew PL; Lee WJ; Lee YC; Wang HH; Wang W; Lin YC
    Obes Surg; 2006 Dec; 16(12):1584-93. PubMed ID: 17217634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lysyl Oxidase as a Serum Biomarker of Liver Fibrosis in Patients with Severe Obesity and Obstructive Sleep Apnea.
    Mesarwi OA; Shin MK; Drager LF; Bevans-Fonti S; Jun JC; Putcha N; Torbenson MS; Pedrosa RP; Lorenzi-Filho G; Steele KE; Schweitzer MA; Magnuson TH; Lidor AO; Schwartz AR; Polotsky VY
    Sleep; 2015 Oct; 38(10):1583-91. PubMed ID: 26085300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective study of the long-term effects of bariatric surgery on liver injury in patients without advanced disease.
    Mathurin P; Hollebecque A; Arnalsteen L; Buob D; Leteurtre E; Caiazzo R; Pigeyre M; Verkindt H; Dharancy S; Louvet A; Romon M; Pattou F
    Gastroenterology; 2009 Aug; 137(2):532-40. PubMed ID: 19409898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Obstructive sleep apnea syndrome affects liver histology and inflammatory cell activation in pediatric nonalcoholic fatty liver disease, regardless of obesity/insulin resistance.
    Nobili V; Cutrera R; Liccardo D; Pavone M; Devito R; Giorgio V; Verrillo E; Baviera G; Musso G
    Am J Respir Crit Care Med; 2014 Jan; 189(1):66-76. PubMed ID: 24256086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bariatric Surgery Reduces Features of Nonalcoholic Steatohepatitis in Morbidly Obese Patients.
    Lassailly G; Caiazzo R; Buob D; Pigeyre M; Verkindt H; Labreuche J; Raverdy V; Leteurtre E; Dharancy S; Louvet A; Romon M; Duhamel A; Pattou F; Mathurin P
    Gastroenterology; 2015 Aug; 149(2):379-88; quiz e15-6. PubMed ID: 25917783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histological and immunohistochemical assessment of liver biopsies in morbidly obese patients.
    Caballero T; Gila A; Sánchez-Salgado G; Muñoz de Rueda P; León J; Delgado S; Muñoz JA; Caba-Molina M; Carazo A; Ruiz-Extremera A; Salmerón J
    Histol Histopathol; 2012 Apr; 27(4):459-66. PubMed ID: 22374723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Obstructive sleep apnea-hypopnea syndrome and nonalcoholic fatty liver disease: emerging evidence and mechanisms.
    Musso G; Olivetti C; Cassader M; Gambino R
    Semin Liver Dis; 2012 Feb; 32(1):49-64. PubMed ID: 22418888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated expression of osteopontin may be related to adipose tissue macrophage accumulation and liver steatosis in morbid obesity.
    Bertola A; Deveaux V; Bonnafous S; Rousseau D; Anty R; Wakkach A; Dahman M; Tordjman J; Clément K; McQuaid SE; Frayn KN; Huet PM; Gugenheim J; Lotersztajn S; Le Marchand-Brustel Y; Tran A; Gual P
    Diabetes; 2009 Jan; 58(1):125-33. PubMed ID: 18952835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver enzymes and histology in obese patients with obstructive sleep apnea.
    Kallwitz ER; Herdegen J; Madura J; Jakate S; Cotler SJ
    J Clin Gastroenterol; 2007; 41(10):918-21. PubMed ID: 18090161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between obstructive sleep apnea and liver abnormalities in morbidly obese patients: a prospective study.
    Jouët P; Sabaté JM; Maillard D; Msika S; Mechler C; Ledoux S; Harnois F; Coffin B
    Obes Surg; 2007 Apr; 17(4):478-85. PubMed ID: 17608260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histopathologic variability between the right and left lobes of the liver in morbidly obese patients undergoing Roux-en-Y bypass.
    Larson SP; Bowers SP; Palekar NA; Ward JA; Pulcini JP; Harrison SA
    Clin Gastroenterol Hepatol; 2007 Nov; 5(11):1329-32. PubMed ID: 17702661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver visfatin expression in morbidly obese patients with nonalcoholic fatty liver disease undergoing bariatric surgery.
    Kukla M; Ciupińska-Kajor M; Kajor M; Wyleżoł M; Żwirska-Korczala K; Hartleb M; Berdowska A; Mazur W
    Pol J Pathol; 2010; 61(3):147-53. PubMed ID: 21225497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of nonalcoholic steatohepatitis in Japanese patients with morbid obesity undergoing bariatric surgery.
    Seki Y; Kakizaki S; Horiguchi N; Hashizume H; Tojima H; Yamazaki Y; Sato K; Kusano M; Yamada M; Kasama K
    J Gastroenterol; 2016 Mar; 51(3):281-9. PubMed ID: 26314837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.